drugset / Trial / NCT02216071
Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to demonstrate the clinical therapeutic non-inferiority of EXL CDOS to commercially available Ciprofloxacin 0.3% and Dexamethasone 0.1% Sterile Otic Suspension (Ciprodex®, Alcon) in the treatment of acute otitis externa (AOE) when administered twice daily for 7 days.
Timeline
- Start
- 2014-07-20
- Primary completion
- 2015-08-11
- Completion
- 2015-08-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciprofloxacin | Small molecule | 0.3 % | — |
| Subject | Dexamethasone | Small molecule | 0.1 % | — |